Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOtaiku, Eyiowuawi Toluwalase-
dc.date.accessioned2022-06-24T08:47:21Z-
dc.date.available2022-06-24T08:47:21Z-
dc.date.issued2019-
dc.identifier.citationOtaiku Eyiowuawi Toluwalase (2019). Molecular Characterization of Fungi from Pharmaceutical Productsen_US
dc.identifier.other15010101013-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/192-
dc.description.abstractStudies on Fungi isolated from pharmaceutical products from pharmacy and stores were carried out between the month of April 2019 and July 2019. Collection, isolation, characterization and identification of the isolated Fungi were achieved using both conventional laboratory methods and molecular methods (DNA extraction, PCR and DNA sequencing).Thirteen fungi was isolated out of which seven fungal species were identified and they include Aspergillus tamari strain A, Aspergillus tubingenesis strain, Aspergillus tamari strain B, Aspergillus ellipticus, Aspergillus niger strain A, Aspergillus niger strain B, Aspergillus niger strain C, from the pharmaceutical drugs sampled using 3 protocols. The result of the BLAST DNA sequence database of the isolated fungi revealed that no sequence data was 100% homologous with those in the Gene bank.en_US
dc.language.isoenen_US
dc.publisherMountain Top Universityen_US
dc.subjectDNAen_US
dc.subjectFungien_US
dc.titleMolecular Characterization of Fungi from Pharmaceutical Productsen_US
dc.typeOtheren_US
Appears in Collections:Microbiology

Files in This Item:
File Description SizeFormat 
otaiku-eyiowuawi-toluwalase-microbiology-2019docx.pdf654.17 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.